MONKEYPOX VACCINE EFFICACY IS BELOW 100%: WHO

Thu 18 August 2022:

People must reduce their own risks of infection, because vaccines against monkeypox are not 100% effective, WHO technical lead Rosamund Lewis said on Wednesday.

“We are not expecting a 100% efficacy for these vaccines for the prevention of monkeypox. We don’t have the exact information … it reminds us that vaccine is not a silver bullet? That every person who feels that they are at risk and appreciates the level of risk and wishes to lower their risk have many interventions at their disposal, which includes vaccination where available, but also includes protection from activities, where they may be at risk,” Lewis said during a briefing.

In July, WHO Director-General Tedros Adhanom Ghebreyesus announced that the global monkeypox outbreak represents a public health emergency of international concern.

Most people usually recover from monkeypox within a few weeks without treatment.

The symptoms are initially flu-like, such as fever, chills, and swollen lymph nodes, which are then followed by a widespread rash. According to the WHO, the disease can be more severe in young children, pregnant women, and individuals who are immunocompromised.

The virus that causes monkeypox is difficult to spread and typically does so through close physical contact, including sexual contact, with an infected person. The respiratory system, eyes, nose, mouth, and bodily fluids are only a few of the entry points for the virus into the human body. It’s a zoonotic disease, monkeypox. It develops in rodents and primates, and it occurs in isolated regions of Central and West Africa.

More than 70 nations have reported over 31,000 cases of monkeypox, and the illness is believed to be responsible for 12 fatalities.

NEWS AGENCIES

___________________________________________________________________________________________________________________________________________

FOLLOW INDEPENDENT PRESS:

TWITTER (CLICK HERE)
https://twitter.com/IpIndependent